Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial-Reference-Cited by-同舟云学术

Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial

Published:2010-04 Issue:4 Volume:28 Page:865-874
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Thijs Lutgarde,Richart Tom,de Leeuw Peter W,Kuznetsova Tatiana,Grodzicki Tomasz,Kawecka-Jaszcz Kalina,O'Brien Eoin,Redón Josep,Birkenhäger Willem H,Fagard Robert,Staessen Jan A

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference30 articles.

1. Neglected global epidemics: three growing threats;Bonita,2003

2. High remaining risk in poorly treated hypertension: the ‘rule of halves’ still exist;Weinehall;J Hypertens,2002

3. 2007 guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;J Hypertens,2007

4. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Chobanian;Hypertension,2003

5. Predictors of adherence with antihypertensive and lipid-lowering therapy;Chapman;Arch Intern Med,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost;The Journal of Clinical Hypertension;2020-08-20

2. Nurse Led Interventions in Hypertension;Drug Adherence in Hypertension and Cardiovascular Protection;2018

3. Morbidity and mortality on combination versus monotherapy;Journal of Hypertension;2016-03

4. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol;American Heart Journal;2014-02

5. Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension;Expert Opinion on Pharmacotherapy;2012-11-30